Intec Pharma (Israel) Alpha and Beta Analysis

NTEC -- Israel Stock  

null 1,495  5.00  0.34%

This module allows you to check different measures of market premium for Intec Pharma Ltd as well as systematic risk associated with investing in Intec Pharma over a specified time horizon. Please see also Stocks Correlation.
Horizon     30 Days    Login   to change
Symbol
Run Premiums

Intec Pharma Market Premiums

α0.00   β0.00
30 days against DJI

Intec Pharma Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Intec Pharma to competition

Intec Pharma Fundamental Vs Peers

FundamentalsIntec PharmaPeer Average
Return On Equity(98.29)%
Return On Asset(41.22)%
Current Valuation385.58M
Shares Outstanding33.23M
Price to Book805.45X
EBITDA(34.63M)
Net Income(35.14M)

Intec Pharma Opportunities

Intec Pharma Return and Market Media

The median price of Intec Pharma for the period between Sat, Feb 23, 2019 and Wed, Apr 24, 2019 is 1582.0 with a coefficient of variation of 32.32. The daily time series for the period is distributed with a sample standard deviation of 463.05, arithmetic mean of 1432.66, and mean deviation of 260.48. The Stock received some media coverage during the period.
 Price Growth (%)  
      Timeline 
1
Jane Street Group LLC Takes Position in Intec Pharma Ltd08/08/2018

Search macroaxis.com